Metabolic signatures in apoptotic human cancer cell lines

OMICS A Journal of Integrative Biology

Volumn 15, Issue 5, 2011, Pages 325-335

  Halama, Anna ^a   Möller, Gabriele ^a   Adamski, Jerzy ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; BIOLOGICAL MARKER; CASPASE 3; CASPASE 7; GLUTAMIC ACID; GLYCINE; METHIONINE; PROPIONYLCARNITINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; METABOLITE; METABOLOME; METABOLOMICS; PRIORITY JOURNAL; RELIABILITY;

APOPTOSIS; BIOLOGICAL MARKERS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; HEK293 CELLS; HEP G2 CELLS; HUMANS; METABOLOME; METABOLOMICS; NEOPLASMS; STAUROSPORINE;

EID: 79956094953     PISSN: 15362310     EISSN: 15362310     Source Type: Journal    
DOI: 10.1089/omi.2010.0121     Document Type: Article

References (57)

1. Alberici, A., Moratto, D., Benussi, L., Gasparini, L., Ghidoni, R., Gatta, L.B., et al. (1999). Presenilin 1 protein directly interacts with Bcl-2. J Biol Chem 274, 30764-30769.
2. Altmaier, E., Kastenmuller, G., Romisch-Margl, W., Thorand, B., Weinberger, K.M., Adamski, J., et al. (2009). Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics. Mol Nutr Food Res 53, 1357-1365.
3. Altun, Z.S., Gunes, D., Aktas, S., Erbayraktar, Z., and Olgun, N. (2009). Protective effects of acetyl-L-carnitine on cisplatin cytotoxicity and oxidative stress in neuroblastoma. Neurochem Res 35, 437-443.
4. Bais, P., Moon, S.M., He, K., Leitao, R., Dreher, K., Walk, T., et al. (2010). PlantMetabolomics.org: a web portal for plant metabolomics experiments. Plant Physiol 152, 1807-1816.
5. Baumgartner, C., Bohm, C., Baumgartner, D., Marini, G., Weinberger, K., Olgemoller, B., Liebl, B., et al. (2004). Supervised machine learning techniques for the classification of metabolic disorders in newborns. Bioinformatics 20, 2985-2996. (Pubitemid 39619190)
6. Bertrand, R., Solary, E., O'Connor, P., Kohn, K.W., and Pommier, Y. (1994). Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 211, 314-321. (Pubitemid 24174963)
7. Caballero-Benitez, A., and Moran, J. (2003). Caspase activation pathways induced by staurosporine and low potassium: role of caspase-2. J Neurosci Res 71, 383-396. (Pubitemid 36159497)
8. Call, J.A., Eckhardt, S.G., and Camidge, D.R. (2008). Targeted manipulation of apoptosis in cancer treatment. Lancet Oncol 9, 1002-1011.
9. Ceglarek, U., Shackleton, C., Stanczyk, F.Z., and Adamski, J. (2010). Steroid profiling and analytics: going towards sterome. J Steroid Biochem Mol Biol 121, 479-480.
10. Chace, D.H., Kalas, T.A., and Naylor, E.W. (2003). Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49, 1797-1817. (Pubitemid 37340314)
11. Cuperlovic-Culf, M., Barnett, D.A., Culf, A.S., and Chute, I. (2010). Cell culture metabolomics: applications and future directions. Drug Discov Today 15, 610-621.
12. Danial, N.N., and Korsmeyer, S.J. (2004). Cell death: critical control points. Cell 116, 205-219. (Pubitemid 38167313)
13. Edelman, M.J., Bauer, K.S., Jr., Wu, S., Smith, R., Bisacia, S., and Dancey, J. (2007). Phase I and pharmacokinetic study of 7- hydroxystaurosporine and carboplatin in advanced solid tumors. Clin Cancer Res 13, 2667-2674. (Pubitemid 46788034)
14. Edinger, A.L., and Thompson, C.B. (2004). Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16, 663-669. (Pubitemid 39463117)
15. Ellis, D.I., Dunn, W.B., Griffin, J.L., Allwood, J.W., and Goodacre, R. (2007). Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 8, 1243-1266. (Pubitemid 47578232)
16. Flanagan, J.L., Simmons, P.A., Vehige, J., Willcox, M.D., and Garrett, Q. (2010). Role of carnitine in disease. Nutr Metab (Lond) 7, 30.
17. Gallagher, W.M., Tweats, D., and Koenig, J. (2009). Omic profiling for drug safety assessment: current trends and public- private partnerships. Drug Discov Today 14, 337-342.
18. Garcia-Alvarez, I., Garrido, L., Doncel-Perez, E., Nieto-Sampedro, M., and Fernandez-Mayoralas, A. (2009). Detection of metabolite changes in C6 glioma cells cultured with antimitotic oleyl glycoside by 1H MAS NMR. J Med Chem 52, 1263-1267.
19. Goodacre, R. (2007). Metabolomics of a superorganism. J Nutr 137, 259S-266S. (Pubitemid 46070106)
20. Griffin, J.L., and Shockcor, J.P. (2004). Metabolic profiles of cancer cells. Nat Rev Cancer 4, 551-561. (Pubitemid 38868624)
21. Griffiths, W.J., and Wang, Y. (2009). Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem Soc Rev 38, 1882-1896.
22. Griffiths, W.J., Karu, K., Hornshaw, M., Woffendin, G., and Wang, Y. (2007). Metabolomics and metabolite profiling: past heroes and future developments. Eur J Mass Spectrom (Chichester, Eng) 13, 45-50.
23. Illig, T., Gieger, C., Zhai, G., Romisch-Margl, W., Wang-Sattler, R., Prehn, C., et al. (2010). A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42, 137-141.
24. Iyer, S.S., Pulskens, W.P., Sadler, J.J., Butter, L.M., Teske, G.J., Ulland, T.K., et al. (2009). Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 106, 20388-20393.
25. Kastenmüller, G., Römisch-Margl, W., Wägele, B., Altmeier, E., and Suhre, K. (2010). metaP-Server: A Web-based metabolomicsdata analysis tool. J Biomed Biotechnol 2011, ID839862.
26. Kim, K., Aronov, P., Zakharkin, S.O., Anderson, D., Perroud, B., Thompson, I.M., and Weiss, R.H. (2009). Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8, 558-570.
27. Koulman, A., Lane, G.A., Harrison, S.J., and Volmer, D.A. (2009). From differentiating metabolites to biomarkers. Anal Bioanal Chem 394, 663-670.
28. Kovacevic, Z., and Morris, H.P. (1972). The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res 32, 326-333.
29. Lawton, K.A., Berger, A., Mitchell, M., Milgram, K.E., Evans, A.M., Guo, L., et al. (2008). Analysis of the adult human plasma metabolome. Pharmacogenomics 9, 383-397. (Pubitemid 351803924)
30. Marcelli, M., Marani, M., Li, X., Sturgis, L., Haidacher, S.J., Trial, J.A., et al. (2000). Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation. Prostate 42, 260-273. (Pubitemid 30104569)
31. Mazzarelli, P., Pucci, S., Bonanno, E., Sesti, F., Calvani, M., and Spagnoli, L.G. (2007). Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? Cancer Biol Ther 6, 1606-1613. (Pubitemid 351590333)
32. Mirbahai, L., Wilson, M., Shaw, C.S., McConville, C., Malcomson, R.D., Griffin, J.L., et al. (2010). (1)H magnetic resonance spectroscopy metabolites as biomarkers for cell cycle arrest and cell death in rat glioma cells. Int J Biochem Cell Biol.
33. Miyamoto, Y., Takikawa, Y., De Lin, S., Sato, S., and Suzuki, K. (2004). Apoptotic hepatocellular carcinoma HepG2 cells accelerate blood coagulation. Hepatol Res 29, 167-172. (Pubitemid 38780133)
34. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63. (Pubitemid 14203433)
35. Nagata, E., Luo, H.R., Saiardi, A., Bae, B.I., Suzuki, N., and Snyder, S.H. (2005). Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death. J Biol Chem 280, 1634-1640.
36. Ohta, T., Masutomi, N., Tsutsui, N., Sakairi, T., Mitchell, M., Milburn, M.V., et al. (2009). Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol 37, 521-535.
37. Olopade, O.I., Adeyanju, M.O., Safa, A.R., Hagos, F., Mick, R., Thompson, C.B., et al. (1997). Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 3, 230-237.
38. Oresic, M. (2009). Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction. Nutr Metab Cardiovasc Dis 19, 816-824.
39. Perez, R.P., Lewis, L.D., Beelen, A.P., Olszanski, A.J., Johnston, N., Rhodes, C.H., et al. (2006). Modulation of cell cycle progression in human tumors: a pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850). Clin Cancer Res 12, 7079-7085. (Pubitemid 44974507)
40. Picard, F.J., and Bergeron, M.G. (2002). Rapid molecular theranostics in infectious diseases. Drug Discov Today 7, 1092-1101. (Pubitemid 35341650)
41. Proskuryakov, S.Y., Konoplyannikov, A.G., and Gabai, V.L. (2003). Necrosis: a specific form of programmed cell death? Exp Cell Res 283, 1-16. (Pubitemid 36259891)
42. Rainaldi, G., Romano, R., Indovina, P., Ferrante, A., Motta, A., Indovina, P.L., et al. (2008). Metabolomics using 1H-NMR of apoptosis and Necrosis in HL60 leukemia cells: differences between the two types of cell death and independence from the stimulus of apoptosis used. Radiat Res 169, 170-180. (Pubitemid 351295074)
43. Rashed, M.S., Bucknall, M.P., Little, D., Awad, A., Jacob, M., Alamoudi, M., et al. (1997). Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 43, 1129-1141. (Pubitemid 27297255)
44. Rios-Estepa, R., Turner, G.W., Lee, J.M., Croteau, R.B., and Lange, B.M. (2008). A systems biology approach identifies the biochemical mechanisms regulating monoterpenoid essential oil composition in peppermint. Proc Natl Acad Sci USA 105, 2818-2823. (Pubitemid 351723627)
45. Salomons, G.S., Smets, L.A., Verwijs-Janssen, M., Hart, A.A., Haarman, E.G., Kaspers, G.J., et al. (1999). Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia 13, 1574-1580. (Pubitemid 29465620)
46. Schwartzman, R.A., and Cidlowski, J.A. (1993). Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 14, 133-151. (Pubitemid 23118413)
47. Snyder, M., and Gallagher, J.E. (2009). Systems biology from a yeast omics perspective. FEBS Lett 583, 3895-3899.
48. Sreekumar, A., Poisson, L.M., Rajendiran, T.M., Khan, A.P., Cao, Q., Yu, J., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914.
49. Stepczynska, A., Lauber, K., Engels, I.H., Janssen, O., Kabelitz, D., Wesselborg, S., et al. (2001). Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 20, 1193-1202. (Pubitemid 32226245)
50. Szeliga, M., and Obara-Michlewska, M. (2009). Glutamine in neoplastic cells: focus on the expression and roles of glutaminases. Neurochem Int 55, 71-75.
51. Tiziani, S., Lodi, A., Khanim, F.L., Viant, M.R., Bunce, C.M., and Gunther, U.L. (2009). Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. PLoS One 4, e4251.
52. Wagle, S.R., Morris, H.P., and Weber, G. (1963). Comparative biochemistry of hepatomas. V. Studies on amino acid incorporation in liver tumors of different growth rates. Cancer Res 23, 1003-1007.
53. Ward, T.H., Cummings, J., Dean, E., Greystoke, A., Hou, J.M., Backen, A., et al. (2008). Biomarkers of apoptosis. Br J Cancer 99, 841-846.
54. Weljie, A.M., and Jirik, F.R. (2010). Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect. Int J Biochem Cell Biol.
55. Weljie, A.M., Newton, J., Mercier, P., Carlson, E., and Slupsky, C.M. (2006). Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78, 4430-4442.
56. Wyllie, A.H. (1997). Apoptosis: an overview. Br Med Bull 53, 451-465. (Pubitemid 27397303)
57. Xu, E.Y., Schaefer, W.H., and Xu, Q. (2009). Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Curr Opin Drug Discov Dev 12, 40-52.